Product NDC: | 0409-2689 |
Proprietary Name: | Ampicillin and Sulbactam |
Non Proprietary Name: | Ampicillin sodium and Sulbactam sodium |
Active Ingredient(s): | 1; .5 g/1; g/1 & nbsp; Ampicillin sodium and Sulbactam sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2689 |
Labeler Name: | Hospira, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065241 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060725 |
Package NDC: | 0409-2689-11 |
Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-11) |
NDC Code | 0409-2689-11 |
Proprietary Name | Ampicillin and Sulbactam |
Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-11) |
Product NDC | 0409-2689 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ampicillin sodium and Sulbactam sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060725 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc |
Substance Name | AMPICILLIN SODIUM; SULBACTAM SODIUM |
Strength Number | 1; .5 |
Strength Unit | g/1; g/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC] |